The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126898481 12689848 1 I 20160107 20160815 20160826 20160826 EXP GB-MHRA-EYC 00143073 GB-TEVA-685648ACC TEVA 49.00 YR M Y 75.00000 KG 20160826 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126898481 12689848 1 PS CIPROFLOXACIN. CIPROFLOXACIN 1 1000 MILLIGRAM DAILY; 1000 MG U NOT KNOWN 74124 500 MG TABLET BID
126898481 12689848 2 SS CIPROFLOXACIN. CIPROFLOXACIN 1 500 MILLIGRAM DAILY; 1000 MG U NOT KNOWN 74124 250 MG TABLET BID
126898481 12689848 3 C IBUPROFEN. IBUPROFEN 1 400 MILLIGRAM DAILY; 73583.3333 MG 0 200 MG TABLET BID
126898481 12689848 4 C OMEGA-3 FISH OIL FISH OILOMEGA-3 FATTY ACIDS 1 0
126898481 12689848 5 C TURMERIC TURMERIC 1 0
126898481 12689848 6 C VITAMIN D3 CHOLECALCIFEROL 1 0
126898481 12689848 7 C CHIROCAINE LEVOBUPIVACAINE HYDROCHLORIDE 1 2.5MG/ML LONG-ACTING LOCAL 0 5 ML
126898481 12689848 8 C MAGNEVIST GADOPENTETATE DIMEGLUMINE 1 0
126898481 12689848 9 C OMNIPAQUE IOHEXOL 1 0
126898481 12689848 10 C LIDOCAINE. LIDOCAINE 1 SMALL DOSE OF SHORT-ACTING LOCAL IN SKIN. 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126898481 12689848 1 Prostatitis
126898481 12689848 3 Inflammation

Outcome of event

Event ID CASEID OUTC COD
126898481 12689848 DS
126898481 12689848 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126898481 12689848 Arthralgia
126898481 12689848 Arthropathy
126898481 12689848 Back pain
126898481 12689848 Depression
126898481 12689848 Dry eye
126898481 12689848 Eye discharge
126898481 12689848 Eye pain
126898481 12689848 Fatigue
126898481 12689848 Feeling abnormal
126898481 12689848 Foreign body sensation in eyes
126898481 12689848 Formication
126898481 12689848 Hypersomnia
126898481 12689848 Joint stiffness
126898481 12689848 Lymphadenopathy
126898481 12689848 Malaise
126898481 12689848 Muscle spasms
126898481 12689848 Muscle twitching
126898481 12689848 Musculoskeletal stiffness
126898481 12689848 Myalgia
126898481 12689848 Pain in extremity
126898481 12689848 Panic attack
126898481 12689848 Paraesthesia
126898481 12689848 Skin burning sensation
126898481 12689848 Tendon disorder
126898481 12689848 Tinnitus
126898481 12689848 Toxicity to various agents
126898481 12689848 Vision blurred
126898481 12689848 Vitreous floaters

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126898481 12689848 1 20160107 20160113 0
126898481 12689848 2 20160114 20160203 0
126898481 12689848 3 20160709 20160709 0
126898481 12689848 4 20160101 0
126898481 12689848 5 20160701 0
126898481 12689848 6 20160130 0
126898481 12689848 7 20160708 20160708 0
126898481 12689848 8 20160708 20160708 0
126898481 12689848 9 20160708 20160708 0
126898481 12689848 10 20160708 20160708 0